Inflammation-induced depression: Its pathophysiology and therapeutic implications

Sang Won Jeon, Yong Ku Kim

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

Inflammation is not the only cause of depression and cannot explain its entire pathophysiology, but it is an important pathogenic factor that explains one possible mechanism of depression, with the kynurenine (KYN) pathway of tryptophan at its center. In particular, greater impairment seems to exist in the KYN pathway in inflammation-induced depression related to immunotherapy, autoimmune disease, and infection. In patients with these conditions, immunopharmacology is likely to be an important therapy. To develop this therapy, clear evidence of the immune-KYN pathway must be established via multiple types of experiments. This paper reviews the body of evidence, not only for the action of tryptophan (TRY) and consequent serotonin depletion, but also for the detrimental effects of TRY catabolites and the key enzymes in the KYN pathway that play important roles in the pathophysiology of inflammation-induced depression. In addition, this paper explores a potential treatment strategy for inflammation-induced depression using KYN metabolism.

Original languageEnglish
Pages (from-to)92-98
Number of pages7
JournalJournal of Neuroimmunology
Volume313
DOIs
Publication statusPublished - 2017 Dec 15

Fingerprint

Kynurenine
Inflammation
Tryptophan
Therapeutics
Immunotherapy
Autoimmune Diseases
Serotonin
Enzymes
Infection

Keywords

  • Depression
  • Immunopharmacology
  • Inflammation
  • Kynurenine pathway
  • Tryptophan

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

Inflammation-induced depression : Its pathophysiology and therapeutic implications. / Jeon, Sang Won; Kim, Yong Ku.

In: Journal of Neuroimmunology, Vol. 313, 15.12.2017, p. 92-98.

Research output: Contribution to journalReview article

@article{c6f247ad0e9844fdafaf994f53b95b1f,
title = "Inflammation-induced depression: Its pathophysiology and therapeutic implications",
abstract = "Inflammation is not the only cause of depression and cannot explain its entire pathophysiology, but it is an important pathogenic factor that explains one possible mechanism of depression, with the kynurenine (KYN) pathway of tryptophan at its center. In particular, greater impairment seems to exist in the KYN pathway in inflammation-induced depression related to immunotherapy, autoimmune disease, and infection. In patients with these conditions, immunopharmacology is likely to be an important therapy. To develop this therapy, clear evidence of the immune-KYN pathway must be established via multiple types of experiments. This paper reviews the body of evidence, not only for the action of tryptophan (TRY) and consequent serotonin depletion, but also for the detrimental effects of TRY catabolites and the key enzymes in the KYN pathway that play important roles in the pathophysiology of inflammation-induced depression. In addition, this paper explores a potential treatment strategy for inflammation-induced depression using KYN metabolism.",
keywords = "Depression, Immunopharmacology, Inflammation, Kynurenine pathway, Tryptophan",
author = "Jeon, {Sang Won} and Kim, {Yong Ku}",
year = "2017",
month = "12",
day = "15",
doi = "10.1016/j.jneuroim.2017.10.016",
language = "English",
volume = "313",
pages = "92--98",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",

}

TY - JOUR

T1 - Inflammation-induced depression

T2 - Its pathophysiology and therapeutic implications

AU - Jeon, Sang Won

AU - Kim, Yong Ku

PY - 2017/12/15

Y1 - 2017/12/15

N2 - Inflammation is not the only cause of depression and cannot explain its entire pathophysiology, but it is an important pathogenic factor that explains one possible mechanism of depression, with the kynurenine (KYN) pathway of tryptophan at its center. In particular, greater impairment seems to exist in the KYN pathway in inflammation-induced depression related to immunotherapy, autoimmune disease, and infection. In patients with these conditions, immunopharmacology is likely to be an important therapy. To develop this therapy, clear evidence of the immune-KYN pathway must be established via multiple types of experiments. This paper reviews the body of evidence, not only for the action of tryptophan (TRY) and consequent serotonin depletion, but also for the detrimental effects of TRY catabolites and the key enzymes in the KYN pathway that play important roles in the pathophysiology of inflammation-induced depression. In addition, this paper explores a potential treatment strategy for inflammation-induced depression using KYN metabolism.

AB - Inflammation is not the only cause of depression and cannot explain its entire pathophysiology, but it is an important pathogenic factor that explains one possible mechanism of depression, with the kynurenine (KYN) pathway of tryptophan at its center. In particular, greater impairment seems to exist in the KYN pathway in inflammation-induced depression related to immunotherapy, autoimmune disease, and infection. In patients with these conditions, immunopharmacology is likely to be an important therapy. To develop this therapy, clear evidence of the immune-KYN pathway must be established via multiple types of experiments. This paper reviews the body of evidence, not only for the action of tryptophan (TRY) and consequent serotonin depletion, but also for the detrimental effects of TRY catabolites and the key enzymes in the KYN pathway that play important roles in the pathophysiology of inflammation-induced depression. In addition, this paper explores a potential treatment strategy for inflammation-induced depression using KYN metabolism.

KW - Depression

KW - Immunopharmacology

KW - Inflammation

KW - Kynurenine pathway

KW - Tryptophan

UR - http://www.scopus.com/inward/record.url?scp=85032689097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032689097&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2017.10.016

DO - 10.1016/j.jneuroim.2017.10.016

M3 - Review article

C2 - 29153615

AN - SCOPUS:85032689097

VL - 313

SP - 92

EP - 98

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

ER -